Does structural worsening of osteoarthritis predict clinical worsening?

EUROVISCO Recommendations for the Use of Viscosupplementation with Hyaluronic Acid in the Management of Hip Osteoarthritis.

Cartilage·2026

A new biochemical score from synovial fluid for diagnosing septic arthritis.

Joint bone spine·2025

Intra-articular MM-II for the treatment of knee osteoarthritis pain: Efficacy and safety results from a 26-week, phase 2b, placebo-controlled, double-blind, randomized dose-ranging trial.

Osteoarthritis and cartilage·2025

EUROVISCO Good Medical Practice Recommendations for the Use of Viscosupplementation with Hyaluronic Acid in the Management of Knee Osteoarthritis.

Cartilage·2025

Protocol for a multicentre randomised triple-blind controlled trial assessing the clinical efficacy of intra-articular platelet-rich plasma injections versus placebo in symptomatic knee osteoarthritis (PIKOA).

BMJ open·2024

EUROVISCO Consensus Guidelines for the Use of Hyaluronic Acid Viscosupplementation in Knee Osteoarthritis Based on Patient Characteristics.

Cartilage·2024

Current Diagnostic Pathways for Rheumatoid Arthritis-Associated Interstitial Lung Disease Result in Substantial Underdiagnosis and Excess Mortality: A Multicenter Norwegian Quality Assurance Audit.

Joint bone spine·2026

Residual activated Th17 cells during inactive disease or low disease activity are associated with subsequent disease worsening in radiographic axial spondyloarthritis: a pilot study.

Joint bone spine·2026

Plasma Metabolic and Proteomic Signatures of Mixed Exposure to Ambient Air Pollutants Associated with Incident Arthritis Subtypes.

Joint bone spine·2026

Long-term sequelae in patients with spondylodiscitis: independent predictors.

Joint bone spine·2026

A comparison of meta-analyses on articular treatments for knee osteoarthritis-related pain, indexed in PubMed until March 2025.

Joint bone spine·2026

Beyond Uric Acid: Allantoin Reflects Oxidative Stress, Disease Burden, and Cardiovascular Comorbidities in Hyperuricemia and Gout.

Joint bone spine·2026

Factors Associated With Omalizumab Response in Chronic Spontaneous Urticaria: Are There Age-Related Differences?

Acta paediatrica (Oslo, Norway : 1992)·2026

[Immobilizing back pain in an elderly patient: Differential diagnostic considerations and diagnosis].

Praxis·2026

Case report of three cases and literature review: is follicular occlusion triad with peripheral/axial spondyloarthritis involvement an analog of SAPHO syndrome?

Frontiers in medicine·2026

Comparison of telitacicept and belimumab in systemic lupus erythematosus: a real-word retrospective study.

Clinical rheumatology·2026

Incidence, baseline-associated factors and burden of difficult-to-manage axial spondyloarthritis: a 10-year analysis of the DESIR cohort.

RMD open·2026

The 2026 ESSKA-ESA formal consensus on partial-thickness posterosuperior rotator cuff tears (Part 1): Definitions, classifications, etiologies, natural history and diagnosis.

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA·2026

Related Experiment Videos

Does structural worsening of osteoarthritis predict clinical worsening?

Related Concept Videos

EUROVISCO Recommendations for the Use of Viscosupplementation with Hyaluronic Acid in the Management of Hip Osteoarthritis.

A new biochemical score from synovial fluid for diagnosing septic arthritis.

Intra-articular MM-II for the treatment of knee osteoarthritis pain: Efficacy and safety results from a 26-week, phase 2b, placebo-controlled, double-blind, randomized dose-ranging trial.

EUROVISCO Good Medical Practice Recommendations for the Use of Viscosupplementation with Hyaluronic Acid in the Management of Knee Osteoarthritis.

Protocol for a multicentre randomised triple-blind controlled trial assessing the clinical efficacy of intra-articular platelet-rich plasma injections versus placebo in symptomatic knee osteoarthritis (PIKOA).

EUROVISCO Consensus Guidelines for the Use of Hyaluronic Acid Viscosupplementation in Knee Osteoarthritis Based on Patient Characteristics.

Current Diagnostic Pathways for Rheumatoid Arthritis-Associated Interstitial Lung Disease Result in Substantial Underdiagnosis and Excess Mortality: A Multicenter Norwegian Quality Assurance Audit.

Residual activated Th17 cells during inactive disease or low disease activity are associated with subsequent disease worsening in radiographic axial spondyloarthritis: a pilot study.

Plasma Metabolic and Proteomic Signatures of Mixed Exposure to Ambient Air Pollutants Associated with Incident Arthritis Subtypes.

Long-term sequelae in patients with spondylodiscitis: independent predictors.

A comparison of meta-analyses on articular treatments for knee osteoarthritis-related pain, indexed in PubMed until March 2025.

Beyond Uric Acid: Allantoin Reflects Oxidative Stress, Disease Burden, and Cardiovascular Comorbidities in Hyperuricemia and Gout.

Factors Associated With Omalizumab Response in Chronic Spontaneous Urticaria: Are There Age-Related Differences?

[Immobilizing back pain in an elderly patient: Differential diagnostic considerations and diagnosis].

Case report of three cases and literature review: is follicular occlusion triad with peripheral/axial spondyloarthritis involvement an analog of SAPHO syndrome?

Comparison of telitacicept and belimumab in systemic lupus erythematosus: a real-word retrospective study.

Incidence, baseline-associated factors and burden of difficult-to-manage axial spondyloarthritis: a 10-year analysis of the DESIR cohort.

The 2026 ESSKA-ESA formal consensus on partial-thickness posterosuperior rotator cuff tears (Part 1): Definitions, classifications, etiologies, natural history and diagnosis.

Related Experiment Videos

Does structural worsening of osteoarthritis predict clinical worsening?

Related Concept Videos

Related Articles